CASEY FONTENOT: Open Payments
NPI 1922481779 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 29 payments from 11 companies in 2025. Trend: 2023 $717 · 2024 $628 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $138 |
| Novo Nordisk Inc | 6 | $102 |
| Lilly USA, LLC | 4 | $82 |
| Exact Sciences Corporation | 3 | $60 |
| Dexcom, Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| ABBVIE INC. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, JARDIANCE, Ozempic, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, MOUNJARO, REXULTI, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
